Froehner Michael, Koch Rainer, Litz Rainer J, Hakenberg Oliver W, Oehlschlaeger Sven, Wirth Manfred P
Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
J Urol. 2008 May;179(5):1823-9; discussion 1829. doi: 10.1016/j.juro.2008.01.023. Epub 2008 Mar 19.
We identified an age range in which comorbidity is most closely associated with premature mortality after radical prostatectomy.
A total of 1,302 patients selected for radical prostatectomy were stratified according to the Charlson score, the American Society of Anesthesiologists physical status classification, the New York Heart Association classification of heart insufficiency and the classification of angina pectoris of the Canadian Cardiovascular Society. Furthermore, patients were subdivided into several age groups. Comorbid mortality and overall mortality were the study end points. The prognostic relevance of the comorbidity classifications was assessed by comparing Mantel-Haenszel HRs, p values and 10-year overall survival rates.
The discriminative capacity of all 4 investigated comorbidity classifications decreased when patients 70.0 years or older were included with decreasing HRs and increasing p values. Except for the American Society of Anesthesiologists classification HRs for comparing the high vs low risk groups tended to decrease and p values simultaneously tended to increase when patients younger than 63.0 years were included. In the age range of between 63.0 and 69.9 years 10-year overall survival rates differed by 14% to 28% between patients with a high vs low comorbid risk compared with 6% to 13% in the whole sample.
The discriminative capacity of the investigated comorbidity classifications was greatest in the age group that was 63.0 to 69.9 years old. In patients younger than 63.0 or older than 70.0 years comorbidity classification seemed to contribute little to the prediction of comorbid mortality.
我们确定了一个年龄范围,在此范围内合并症与根治性前列腺切除术后过早死亡的关联最为密切。
选取1302例行根治性前列腺切除术的患者,根据查尔森评分、美国麻醉医师协会身体状况分类、纽约心脏协会心力衰竭分类以及加拿大心血管学会心绞痛分类进行分层。此外,将患者细分为几个年龄组。合并症死亡率和总死亡率为研究终点。通过比较曼特尔 - 亨泽尔风险比(HRs)、p值和10年总生存率来评估合并症分类的预后相关性。
当纳入70.0岁及以上患者时,所有4种研究的合并症分类的鉴别能力均下降,HRs降低,p值升高。除美国麻醉医师协会分类外,当纳入年龄小于63.0岁的患者时,比较高风险组与低风险组的HRs往往降低,而p值同时往往升高。在63.0至69.9岁的年龄范围内,合并症高风险患者与低风险患者的10年总生存率相差14%至28%,而在整个样本中这一差值为6%至13%。
所研究的合并症分类在63.0至69.9岁年龄组中的鉴别能力最强。在年龄小于63.0岁或大于70.0岁的患者中,合并症分类似乎对合并症死亡率的预测作用不大。